Dewi Vernerey is a research engineer in epidemiology and biostatistics who received a master’s degree cum laude from Joseph Fourier University (Grenoble, France) with a major in engineering statistics. He defended a PhD in epidemiology and statistics in 2016. His PhD research focused on statistical methodology for risk prediction and prognostic score construction in oncology and kidney transplantation.



After working for 10 years in Paris at Gustave Roussy institute, Sanofi-Aventis, INSERM Unit 535 and Necker Hospital, he passed in 2009 the national health and medical research institute (INSERM) competitive examination for a research engineer permanent contract.  

Then, he worked in an epidemiology unit at the Cardiovascular Research Center of Paris (PARCC) located in Georges Pompidou European hospital. In 2013, he decided to join the Methodology and quality of life unit in Oncology (UMQVC) at the University hospital of Besancon with his engineer permanent contract. He teaches statistics, data Analysis and methodology in master’s degree and in medical school. 

Research thematic:

Development and improvement of prognostic and/or predictive tools at population and individual level. 

Main areas of expertise:  

- Statistics and epidemiology

- Clinical trial design ans analysis

- Clinical research

- Genetic epidemiology (linkage and association analyses)

- Oncology

- Solid transplantation (kidney and heart)

- Cardiology

Main ongoing external collaborations :

- GERCOR (Multidisciplinary Group in Oncology)

- Fondation ARCAD (Aide et Recherche en Cancérologie Digestive)

- AGEO (Association des Gastro-Entérologues Oncologues)

- FRENCH (Fédération de Recherche EN Chirurgie)

Tools online

- Prognostic Score and Nomogram to Predict Overall Survival in Locally Advanced Pancreatic Cancer: The PROLAP score 

- Prognostic Nomogram and Score to Predict Overall Survival in Second Line Chemotherapy for Advanced Pancreatic Cancer: The PROSCAP score 


Main publications

sample

AbstractPURPOSE:The MOSAIC (Multicenter International Study of Oxaliplatin/Fluorouracil/Leucovorin in the Adjuvant...

Posted by : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Journal name : JCO

sample

AbstractOBJECTIVES:To assess the long term outcomes of transplantation using expanded criteria donors (ECD; donors aged...

Posted by : Dr. Dewi VERNEREY
Journal name : BMJ

sample

AbstractBACKGROUND:The combination of an anti-VEGF or an anti-EGFR-targeted monoclonal antibody with chemotherapy has...

Posted by : Pr. Franck BONNETAIN, Dr. Dewi VERNEREY
Journal name : Lancet Oncol

sample

Background: In advanced pancreatic ductal adenocarcinoma (aPDAC), there is no consensual strategy for second-line...

Posted by : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN, Mme. Aurelia MEURISSE
Journal name : JNCI J Natl Cancer Inst

Latest publications

sample

In first-line metastatic colorectal cancer (mCRC), baseline prognostic factors allowing death risk and treatment...

Posted by : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Journal name : International Journal of Cancer

sample

AbstractBACKGROUND:The combination of an anti-VEGF or an anti-EGFR-targeted monoclonal antibody with chemotherapy has...

Posted by : Pr. Franck BONNETAIN, Dr. Dewi VERNEREY
Journal name : Lancet Oncol

sample

Abstract Background: Baseline prognostic biomarkers stratifying treatment strategies in first-line metastatic...

Posted by : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Journal name :

sample

Background:The management of locally advanced pancreatic cancer (LAPC) patients remains controversial. Better...

Posted by : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Journal name : British Journal of Cancer

sample

AbstractBACKGROUND:We investigated whether the health-related quality of life (HRQoL) score is a prognostic factor for...

Posted by : Pr. Franck BONNETAIN, Dr. Dewi VERNEREY, Dr. Frederic FITENI
Journal name : EJC

sample

AbstractAIM:Microarray studies identified a subgroup of molecular apocrine tumors (estrogen receptor [ER]...

Posted by : Dr. Dewi VERNEREY
Journal name : Future Oncol

sample

AbstractBackground:Frailty is highly prevalent in elderly people. While significant progress has been made to...

Posted by : Dr. Dewi VERNEREY, Dr. Amélie ANOTA, Dr. Sophie PAGET-BAILLY, Mme. Audrey FOUBERT, Mme. Astrid POZET, Pr. Franck BONNETAIN
Journal name : BMC Geriatrics

sample

AbstractGlioblastoma is the most common malignant brain tumor in adults. Baselinehealth-relatedquality of life (HRQoL)...

Posted by : Mr. Brice PAQUETTE, Dr. Dewi VERNEREY, Dr. Amélie ANOTA, Pr. Franck BONNETAIN
Journal name : Cancer Medicine

sample

AbstractPURPOSE:The MOSAIC (Multicenter International Study of Oxaliplatin/Fluorouracil/Leucovorin in the Adjuvant...

Posted by : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Journal name : JCO

sample

AbstractBackground:Pancreatic adenocarcinoma (PDAC) incidence is increasing worldwide. Several studies have shown...

Posted by : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Journal name : BMC Cancer

Latest News

Latest tools

The R package QoLR allows to compute the scoring of main EORTC quality of life questionnaires and to perform the...

Posted by : Dr. Amélie ANOTA, Dr. Dewi VERNEREY, Dr. Amélie ANOTA, Pr. Franck BONNETAIN, Dr. Amélie ANOTA

The management of locally advanced pancreatic cancer (LAPC) patients remains controversial. Better discrimination for...

Posted by : Pr. Franck BONNETAIN, Dr. Sophie PAGET-BAILLY, Dr. Dewi VERNEREY

Posted by : Pr. Franck BONNETAIN, Dr. Dewi VERNEREY

Currently, the management of advanced pancreatic cancer patients is complex in second-line palliative chemotherapy...

Posted by : Dr. Dewi VERNEREY

2015-2017 © Copyright - UMQVC.org

Website by Pearlweb